Journal article icon

Journal article

MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies

Abstract:
A single intradermal vaccination with MTBVAC given to adult rhesus macaques was well tolerated and conferred a significant improvement in outcome following aerosol exposure to M. tuberculosis compared to that provided by a single BCG vaccination. Vaccination with MTBVAC resulted in a significant reduction in M. tuberculosis infection-induced disease pathology measured using in vivo medical imaging, in gross pathology lesion counts and pathology scores recorded at necropsy, the frequency and severity of pulmonary granulomas and the frequency of recovery of viable M. tuberculosis from extrapulmonary tissues following challenge. The immune profiles induced following immunisation with MTBVAC reflect those identified in human clinical trials of MTBVAC. Evaluation of MTBVAC- and TB peptide-pool-specific T-cell cytokine production revealed a predominantly Th1 response from poly- (IFN-¿+TNF-a+IL2+) and multi-(IFN-¿+TNF-a+) functional CD4 T cells, while only low levels of Th22, Th17 and cytokine-producing CD8 T-cell populations were detected together with low-level, but significant, increases in CFP10-specific IFN-¿ secreting cells. In this report, we describe concordance between immune profiles measured in clinical trials and a macaque pre-clinical study demonstrating significantly improved outcome after M. tuberculosis challenge as evidence to support the continued development of MTBVAC as an effective prophylactic vaccine for TB vaccination campaigns
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41541-020-00262-8

Authors

More by this author
Role:
Author
ORCID:
0000-0001-9481-0079
More by this author
Role:
Author
ORCID:
0000-0002-4188-3423
More by this author
Role:
Author
ORCID:
0000-0001-9056-0308
More by this author
Role:
Author
ORCID:
0000-0002-3401-1205
More by this author
Role:
Author
ORCID:
0000-0002-3612-1926


Publisher:
Nature Research
Journal:
npj Vaccines More from this journal
Volume:
6
Issue:
1
Pages:
4-4
Article number:
4
Publication date:
2021-01-04
DOI:
EISSN:
2059-0105
ISSN:
2059-0105


Language:
English
Keywords:
Pubs id:
1152276
Local pid:
pubs:1152276
Source identifiers:
W3120790509
Deposit date:
2026-02-12
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP